1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalences of epilepsy
5.1.1.2. Rising investment and support from the government
5.1.2. Restraints
5.1.2.1. Patent expiration of the second-generation drugs
5.1.2.2. Availability of substitutes options for pain management
5.1.3. Opportunities
5.1.3.1. Rising drug approvals of anticonvulsant drugs from regulatory bodies
5.1.4. Challenges
5.1.4.1. Steep rise in medicine supply shortage for patients
5.2. Cumulative Impact of COVID-19

6. Anticonvulsants Market, by Drug types
6.1. Introduction
6.2. AMPA
6.3. Barbiturate
6.4. Benzodiazepine
6.5. Carbamate Anticonvulsants
6.6. Carbonic Anhydrase Inhibitor
6.7. Dibenzazepine
6.8. Triazine

7. Anticonvulsants Market, by Application
7.1. Introduction
7.2. Anxiety
7.3. Bipolar Disorder
7.4. Borderline Personality Disorder.
7.5. Epilepsy
7.6. Fibromyalgia
7.7. Migraine
7.8. Neuropathic Pain

8. Americas Anticonvulsants Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Anticonvulsants Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand

10. Europe, Middle East & Africa Anticonvulsants Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Abbott Laboratories
12.2. Astrazeneca PLC
12.3. Bausch Health Companies Inc.
12.4. Biocon Limited
12.5. Cadila Pharmaceuticals Limited
12.6. Cipla, Inc.
12.7. Eisai Co., Ltd. by Royalty Pharma
12.8. GlaxoSmithKline PLC
12.9. Glenmark Pharmaceuticals Ltd.
12.10. GW Pharmaceuticals PLC
12.11. Johnson & Johnson Services, Inc.
12.12. Lundbeck A/S
12.13. Mankind Pharma Ltd
12.14. Merck KGaA
12.15. Novartis AG
12.16. Novo Nordisk A/S
12.17. Otsuka Pharmaceutical
12.18. Pfizer Inc.
12.19. Sanofi S.A
12.20. Sunovion Pharmaceuticals Inc.
12.21. Takeda Pharmaceutical Company Limited
12.22. Teva Pharmaceutical Industries Ltd.
12.23. Wockhardt Limited

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL ANTICONVULSANTS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ANTICONVULSANTS MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL ANTICONVULSANTS MARKET SIZE, BY DRUG TYPES, 2020 VS 2027 (%)
FIGURE 4. GLOBAL ANTICONVULSANTS MARKET SIZE, BY DRUG TYPES, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTICONVULSANTS MARKET SIZE, BY DRUG TYPES, 2027
FIGURE 6. GLOBAL ANTICONVULSANTS MARKET SIZE, BY AMPA, 2018-2027 (USD MILLION)
FIGURE 7. GLOBAL ANTICONVULSANTS MARKET SIZE, BY AMPA, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 8. GLOBAL ANTICONVULSANTS MARKET SIZE, BY BARBITURATE, 2018-2027 (USD MILLION)
FIGURE 9. GLOBAL ANTICONVULSANTS MARKET SIZE, BY BARBITURATE, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 10. GLOBAL ANTICONVULSANTS MARKET SIZE, BY BENZODIAZEPINE, 2018-2027 (USD MILLION)
FIGURE 11. GLOBAL ANTICONVULSANTS MARKET SIZE, BY BENZODIAZEPINE, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 12. GLOBAL ANTICONVULSANTS MARKET SIZE, BY CARBAMATE ANTICONVULSANTS, 2018-2027 (USD MILLION)
FIGURE 13. GLOBAL ANTICONVULSANTS MARKET SIZE, BY CARBAMATE ANTICONVULSANTS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 14. GLOBAL ANTICONVULSANTS MARKET SIZE, BY CARBONIC ANHYDRASE INHIBITOR, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL ANTICONVULSANTS MARKET SIZE, BY CARBONIC ANHYDRASE INHIBITOR, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 16. GLOBAL ANTICONVULSANTS MARKET SIZE, BY DIBENZAZEPINE, 2018-2027 (USD MILLION)
FIGURE 17. GLOBAL ANTICONVULSANTS MARKET SIZE, BY DIBENZAZEPINE, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 18. GLOBAL ANTICONVULSANTS MARKET SIZE, BY TRIAZINE, 2018-2027 (USD MILLION)
FIGURE 19. GLOBAL ANTICONVULSANTS MARKET SIZE, BY TRIAZINE, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL ANTICONVULSANTS MARKET SIZE, BY APPLICATION , 2020 VS 2027 (%)
FIGURE 21. GLOBAL ANTICONVULSANTS MARKET SIZE, BY APPLICATION , 2020 VS 2027 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTICONVULSANTS MARKET SIZE, BY APPLICATION , 2027
FIGURE 23. GLOBAL ANTICONVULSANTS MARKET SIZE, BY ANXIETY, 2018-2027 (USD MILLION)
FIGURE 24. GLOBAL ANTICONVULSANTS MARKET SIZE, BY ANXIETY, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL ANTICONVULSANTS MARKET SIZE, BY BIPOLAR DISORDER, 2018-2027 (USD MILLION)
FIGURE 26. GLOBAL ANTICONVULSANTS MARKET SIZE, BY BIPOLAR DISORDER, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 27. GLOBAL ANTICONVULSANTS MARKET SIZE, BY BORDERLINE PERSONALITY DISORDER., 2018-2027 (USD MILLION)
FIGURE 28. GLOBAL ANTICONVULSANTS MARKET SIZE, BY BORDERLINE PERSONALITY DISORDER., BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 29. GLOBAL ANTICONVULSANTS MARKET SIZE, BY EPILEPSY, 2018-2027 (USD MILLION)
FIGURE 30. GLOBAL ANTICONVULSANTS MARKET SIZE, BY EPILEPSY, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 31. GLOBAL ANTICONVULSANTS MARKET SIZE, BY FIBROMYALGIA, 2018-2027 (USD MILLION)
FIGURE 32. GLOBAL ANTICONVULSANTS MARKET SIZE, BY FIBROMYALGIA, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 33. GLOBAL ANTICONVULSANTS MARKET SIZE, BY MIGRAINE, 2018-2027 (USD MILLION)
FIGURE 34. GLOBAL ANTICONVULSANTS MARKET SIZE, BY MIGRAINE, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 35. GLOBAL ANTICONVULSANTS MARKET SIZE, BY NEUROPATHIC PAIN, 2018-2027 (USD MILLION)
FIGURE 36. GLOBAL ANTICONVULSANTS MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 37. AMERICAS ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 38. ARGENTINA ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 39. BRAZIL ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 40. CANADA ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 41. MEXICO ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. UNITED STATES ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 43. ASIA-PACIFIC ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 44. AUSTRALIA ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 45. CHINA ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 46. INDIA ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. INDONESIA ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. JAPAN ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. MALAYSIA ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. PHILIPPINES ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. SINGAPORE ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 52. SOUTH KOREA ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. TAIWAN ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. THAILAND ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. FRANCE ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. GERMANY ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. ITALY ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. NETHERLANDS ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. QATAR ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 61. RUSSIA ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. SAUDI ARABIA ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. SOUTH AFRICA ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. SPAIN ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 65. UNITED ARAB EMIRATES ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 66. UNITED KINGDOM ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. GLOBAL ANTICONVULSANTS MARKET: FPNV POSITIONING MATRIX
FIGURE 68. GLOBAL ANTICONVULSANTS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 69. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANTICONVULSANTS MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL ANTICONVULSANTS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL ANTICONVULSANTS MARKET SIZE, BY DRUG TYPES, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL ANTICONVULSANTS MARKET SIZE, BY AMPA, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL ANTICONVULSANTS MARKET SIZE, BY BARBITURATE, BY REGION, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL ANTICONVULSANTS MARKET SIZE, BY BENZODIAZEPINE, BY REGION, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL ANTICONVULSANTS MARKET SIZE, BY CARBAMATE ANTICONVULSANTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL ANTICONVULSANTS MARKET SIZE, BY CARBONIC ANHYDRASE INHIBITOR, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL ANTICONVULSANTS MARKET SIZE, BY DIBENZAZEPINE, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL ANTICONVULSANTS MARKET SIZE, BY TRIAZINE, BY REGION, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL ANTICONVULSANTS MARKET SIZE, BY APPLICATION , 2018-2027 (USD MILLION)
TABLE 12. GLOBAL ANTICONVULSANTS MARKET SIZE, BY ANXIETY, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL ANTICONVULSANTS MARKET SIZE, BY BIPOLAR DISORDER, BY REGION, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL ANTICONVULSANTS MARKET SIZE, BY BORDERLINE PERSONALITY DISORDER., BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL ANTICONVULSANTS MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL ANTICONVULSANTS MARKET SIZE, BY FIBROMYALGIA, BY REGION, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL ANTICONVULSANTS MARKET SIZE, BY MIGRAINE, BY REGION, 2018-2027 (USD MILLION)
TABLE 18. GLOBAL ANTICONVULSANTS MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2018-2027 (USD MILLION)
TABLE 19. AMERICAS ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 20. ARGENTINA ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 21. BRAZIL ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 22. CANADA ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 23. MEXICO ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 24. UNITED STATES ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 25. ASIA-PACIFIC ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 26. AUSTRALIA ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 27. CHINA ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 28. INDIA ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 29. INDONESIA ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 30. JAPAN ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 31. MALAYSIA ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 32. PHILIPPINES ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 33. SINGAPORE ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 34. SOUTH KOREA ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 35. TAIWAN ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 36. THAILAND ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 37. EUROPE, MIDDLE EAST & AFRICA ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 38. FRANCE ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 39. GERMANY ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 40. ITALY ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 41. NETHERLANDS ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 42. QATAR ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 43. RUSSIA ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 44. SAUDI ARABIA ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 45. SOUTH AFRICA ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 46. SPAIN ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 47. UNITED ARAB EMIRATES ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 48. UNITED KINGDOM ANTICONVULSANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 49. GLOBAL ANTICONVULSANTS MARKET: SCORES
TABLE 50. GLOBAL ANTICONVULSANTS MARKET: BUSINESS STRATEGY
TABLE 51. GLOBAL ANTICONVULSANTS MARKET: PRODUCT SATISFACTION
TABLE 52. GLOBAL ANTICONVULSANTS MARKET: RANKING
TABLE 53. GLOBAL ANTICONVULSANTS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 54. GLOBAL ANTICONVULSANTS MARKET: MERGER & ACQUISITION
TABLE 55. GLOBAL ANTICONVULSANTS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 56. GLOBAL ANTICONVULSANTS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 57. GLOBAL ANTICONVULSANTS MARKET: INVESTMENT & FUNDING
TABLE 58. GLOBAL ANTICONVULSANTS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 59. GLOBAL ANTICONVULSANTS MARKET: LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
Astrazeneca PLC
Bausch Health Companies Inc.
Biocon Limited
Cadila Pharmaceuticals Limited
Cipla, Inc.
Eisai Co., Ltd. by Royalty Pharma
GlaxoSmithKline PLC
Glenmark Pharmaceuticals Ltd.
GW Pharmaceuticals PLC
Johnson & Johnson Services, Inc.
Lundbeck A/S
Mankind Pharma Ltd
Merck KGaA
Novartis AG
Novo Nordisk A/S
Otsuka Pharmaceutical
Pfizer Inc.
Sanofi S.A
Sunovion Pharmaceuticals Inc.
Takeda Pharmaceutical Company Limited
Teva Pharmaceutical Industries Ltd.
Wockhardt Limited